课题基金 / 基金详情

ANTIPROLIFERATIVE OF INTERFERON ON BREAST CANCER CELLS

ANTIPROLIFERATIVE OF INTERFERON ON BREAST CANCER CELLS
干扰素对乳腺癌细胞的抗增殖作用
批准号:
3192238
负责人:
ANNE W. HAMBURGER
金额:
$10.22万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1991-06-30

项目摘要

项目成果

ANNE W. HAMBURGER的其他基金

相似基金

相关文献

中文摘要
翻译
除了它们的抗病毒活性,干扰素抑制生长, 正常和转化细胞。 IFN介导的机制 生长抑制还不完全清楚。 IFN可以通过以下方式起作用: 干扰生长因子的增殖刺激。 的 本提案的主要目的是通过以下方式了解这些方法: 干扰素(IFN)抑制表皮生长因子 (EGF)刺激的人乳腺肿瘤细胞系S4的生长。 我们实验室的先前数据表明IFN可以抑制S4 EGF的作用是通过阻断EGF的促细胞分裂信号来实现的。 到 更充分地表征IFN在该系统中的作用机制, 我们建议进行以下研究: 具体目标包括: 1. 为了进一步表征IFN对EGF的生物学作用, 刺激S4细胞的生长:我们将评估IFN对S4细胞生长的影响。 生长缓慢的对照和EGF刺激的S4细胞。 我们 然后将确定IFN对EGF诱导的刺激的作用 静止S4细胞的DNA合成。 我们将评估 IFN的生长抑制作用对时间的依赖性 暴露于IFN。 动力学研究将有助于确定是否抑制 是细胞周期特异性的 我们将确定干扰素是否能诱导 EGF反应的抑制是剂量依赖性的, 竞争性或非竞争性的互动。 我们还将 测定微管解离剂的能力, 克服IFN对EGF诱导的DNA刺激的影响 合成. 2. 确定IFN诱导的EGF受体(EGFR)的变化 生理学:IFN诱导的亲和力和数量的变化, EGFR,受体内化,EGFR mRNA转录, 受体结构和磷酸化将被探索。 IFN 诱导早期细胞内信号通路的变化, 检测细胞质游离Ca 2+的变化。 3. 为了表征IFN对EGF诱导表达的影响, 光癌基因c-myc:我们将探讨稳定的变化, EGF处理后对照和IFN处理细胞中c-myc的状态水平 刺激. 我们将确定c-myc转录的变化 是由于转录速率的变化(通过核流失 转录测定)或c-myc mRNA的稳定性。 IFN现在被认为是自然发生的负增长 在限制细胞增殖中可能重要的调节剂 in vivo. 干扰素可以拮抗生长因子介导的变化, 细胞增殖 拟议的研究将澄清机制 干扰素诱导的生长抑制在人类肿瘤细胞系。
英文摘要
In addition to their antiviral activity, IFNs inhibit growth of both normal and transformed cells. The mechanisms of IFN-mediated growth inhibition are not fully understood. IFNs may act by interfering with proliferative stimulus of growth factors. The primary objective of this proposal is to understood the means by which interferon (IFN) inhibits the epidermal-growth factor (EGF)-stimulated growth of a human breast tumor cell line, S4. Previous data from our laboratory indicate IFN may inhibit S4 growth in part by interrupting the mitogenic signal of EGF. To more fully characterize IFN mechanisms of action in this system, we propose the following studies: Specific aims include the following: 1. To further characterize the biological action of IFN on EGF- stimulated growth of S4 cells: We will assess the effect of IFN on logarithmically growing control and EGF-stimulated S4 cells. We will then determine the effect of IFN on EGF-induced stimulation of DNA synthesis by quiescent S4 cells. We will assess the dependence of the growth inhibitory effect of IFN on time of exposure to IFN. Kinetic studies will help determine if inhibition is cell-cycle specific. We will determine if the IFN induced inhibition of EGF response is dose-dependent and characteristic of competitive or noncompetitive interactions. We will also determine the ability of microtubule dissociating agents to overcome IFN's effect on EGF induced stimulation of DNA synthesis. 2. To determine IFN induced changes in EGF receptor (EGFR) physiology: IFN induced changes in the affinity and number of EGFR, receptor internalization, transcription of EGFR mRNA, receptor structure, and phosphorylation will be explored. IFN induced changes in early intracellular signaling pathways such as changes in cytoplasmic free Ca2+ will be examined. 3. To characterize the effect of IFN on EGF induced expression of the photooncogene c-myc: We will explore changes in steady state levels of c-myc in control and IFN treated cells after EGF stimulation. We will determine if changes in c-myc transcription is due to changes in either transcription rates (by nuclear run off transcription assays) or the stability of c-myc mRNA. IFNs are now regarded as naturally occurring negative growth regulators which may be important in restricting cell proliferation in vivo. IFNs can antagonize growth factor-mediated changes in cell proliferation. The studies proposed will clarify mechanisms of IFN-induced growth inhibition in a human tumor cell line.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
  • 批准号:
    8260550
  • 项目类别:
  • 资助金额:
    $28.01万
  • 财政年份:
    2011
  • 负责人:
    ANNE W. HAMBURGER
  • 依托单位:
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
  • 批准号:
    8038769
  • 项目类别:
  • 资助金额:
    $28.01万
  • 财政年份:
    2011
  • 负责人:
    ANNE W. HAMBURGER
  • 依托单位:
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
  • 批准号:
    8447576
  • 项目类别:
  • 资助金额:
    $26.33万
  • 财政年份:
    2011
  • 负责人:
    ANNE W. HAMBURGER
  • 依托单位:
A novel therapy for HER2 positive hormone refractory breast cancer
  • 批准号:
    7943990
  • 项目类别:
  • 资助金额:
    $46.26万
  • 财政年份:
    2009
  • 负责人:
    ANNE W. HAMBURGER
  • 依托单位:
海外基金